A groundbreaking anal preservation theory: sufficient pelvic floor muscle function can retain significant defecation function after in-situ anal reconstruction surgery
Author:
Affiliation:
1. Medical College of Xiamen University
2. Fujian Medical University
3. Zhongshan Hospital of Xiamen University
Abstract
Currently, patients with ultra-low rectal cancer/anal canal cancer usually undergo an abdominoperineal resectionwith sigmoid colostomy. Patients commonly experience a poor quality of life post-surgery, often feeling that their dignity has been compromised. Some patients are even willing to forego treatment rather than lose their anus. To explore the patients with ultra-low rectal/anal canal cancer who have well function of pelvic floor muscle before surgery can still retain clinically significant defecation function after undergoing combined procedures of partial pelvic floor muscle resection and in-situ anal reconstruction. After 6 months postoperatively,patient 1’s Wexner scores was 9, and she reported effective control over bowel movements. After 24 months postoperatively, the Wexner scores was 12 for patient 2, and 16 for patient 3. Patient 2 can effectively suppress fecal discharge, experiencing only 2-3 episodes of fecal incontinence per week. Patient 3 can perceive the urge for defecation and can consciously inhibit bowel movement for approximately 20s. Patients who have well-functioning pelvic floor muscle can undergo combined procedures of partial pelvic floor muscle resection and in-situ anal reconstruction.
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;CA Cancer J Clin,2021
2. Colorectal cancer statistics, 2023;Siegel RL;CA Cancer J Clin,2023
3. Intersphincteric resection for low rectal tumours;Schiessel R;The British journal of surgery,1994
4. Anus-Preserving Surgery in Advanced Low-Lying Rectal Cancer: A Perspective on Oncological Safety of Intersphincteric Resection;Piozzi GN;Cancers (Basel),2021
5. Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumab;Fukuda S;Journal for immunotherapy of cancer,2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3